BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 16959374)

  • 1. Anxiolytic-like effect of the selective neuropeptide Y Y2 receptor antagonist BIIE0246 in the elevated plus-maze.
    Bacchi F; Mathé AA; Jiménez P; Stasi L; Arban R; Gerrard P; Caberlotto L
    Peptides; 2006 Dec; 27(12):3202-7. PubMed ID: 16959374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the neuropeptide Y Y2 receptor antagonist BIIE0246 on sympathetic transmitter release in the pig in vivo.
    Malmström RE; Lundberg JN; Weitzberg E
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):106-11. PubMed ID: 11819028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of ethanol self-administration by the neuropeptide Y (NPY) Y2 receptor antagonist BIIE0246: evidence for sensitization in rats with a history of dependence.
    Rimondini R; Thorsell A; Heilig M
    Neurosci Lett; 2005 Feb; 375(2):129-33. PubMed ID: 15670655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lateral septal infusions of the neuropeptide Y Y2 receptor agonist, NPY(13-36) differentially affect different defensive behaviors in male, Long Evans rats.
    Trent NL; Menard JL
    Physiol Behav; 2013 Feb; 110-111():20-9. PubMed ID: 23274501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY(3-36) on food intake.
    Abbott CR; Small CJ; Kennedy AR; Neary NM; Sajedi A; Ghatei MA; Bloom SR
    Brain Res; 2005 May; 1043(1-2):139-44. PubMed ID: 15862527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptide Y regulates recurrent mossy fiber synaptic transmission less effectively in mice than in rats: Correlation with Y2 receptor plasticity.
    Tu B; Jiao Y; Herzog H; Nadler JV
    Neuroscience; 2006 Dec; 143(4):1085-94. PubMed ID: 17027162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The anti-epileptic actions of neuropeptide Y in the hippocampus are mediated by Y and not Y receptors.
    El Bahh B; Balosso S; Hamilton T; Herzog H; Beck-Sickinger AG; Sperk G; Gehlert DR; Vezzani A; Colmers WF
    Eur J Neurosci; 2005 Sep; 22(6):1417-30. PubMed ID: 16190896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropeptide Y Y1 receptors in the central nucleus of amygdala mediate the anxiolytic-like effect of allopregnanolone in mice: Behavioral and immunocytochemical evidences.
    Deo GS; Dandekar MP; Upadhya MA; Kokare DM; Subhedar NK
    Brain Res; 2010 Mar; 1318():77-86. PubMed ID: 20059983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential roles for neuropeptide Y Y1 and Y5 receptors in anxiety and sedation.
    Sørensen G; Lindberg C; Wörtwein G; Bolwig TG; Woldbye DP
    J Neurosci Res; 2004 Sep; 77(5):723-9. PubMed ID: 15352219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropeptide Y (NPY) prevents depressive-like behavior, spatial memory deficits and oxidative stress following amyloid-β (Aβ(1-40)) administration in mice.
    dos Santos VV; Santos DB; Lach G; Rodrigues AL; Farina M; De Lima TC; Prediger RD
    Behav Brain Res; 2013 May; 244():107-15. PubMed ID: 23396168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptide Y-induced enhancement of the evoked release of newly synthesized dopamine in rat striatum: mediation by Y2 receptors.
    Adewale AS; Macarthur H; Westfall TC
    Neuropharmacology; 2007 May; 52(6):1396-402. PubMed ID: 17382974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infusion of neuropeptide Y into CA3 region of hippocampus produces antidepressant-like effect via Y1 receptor.
    Ishida H; Shirayama Y; Iwata M; Katayama S; Yamamoto A; Kawahara R; Nakagome K
    Hippocampus; 2007; 17(4):271-80. PubMed ID: 17265460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ventricular fibrillation induced by ischemia-reperfusion is not prevented by the NPY Y2 receptor antagonist BIIE0246.
    Ilebekk A; Eriksen M; Sevre K; Aspelin T; Björkman JA; Lyberg T; Nordlander M
    J Cardiovasc Pharmacol Ther; 2006 Sep; 11(3):177-83. PubMed ID: 17056830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infusions of neuropeptide Y into the lateral septum reduce anxiety-related behaviors in the rat.
    Trent NL; Menard JL
    Pharmacol Biochem Behav; 2011 Oct; 99(4):580-90. PubMed ID: 21693128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of neuropeptide Y(2) receptors and suppression of NPY's anti-epileptic actions in the rat hippocampal slice by BIIE0246.
    El Bahh B; Cao JQ; Beck-Sickinger AG; Colmers WF
    Br J Pharmacol; 2002 Jun; 136(4):502-9. PubMed ID: 12055128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The novel, selective, brain-penetrant neuropeptide Y Y2 receptor antagonist, JNJ-31020028, tested in animal models of alcohol consumption, relapse, and anxiety.
    Cippitelli A; Rezvani AH; Robinson JE; Eisenberg L; Levin ED; Bonaventure P; Motley ST; Lovenberg TW; Heilig M; Thorsell A
    Alcohol; 2011 Sep; 45(6):567-76. PubMed ID: 21145691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropeptide Y suppresses absence seizures in a genetic rat model primarily through effects on Y receptors.
    Morris MJ; Gannan E; Stroud LM; Beck-Sickinger AG; O'Brien TJ
    Eur J Neurosci; 2007 Feb; 25(4):1136-43. PubMed ID: 17331209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neuropeptide Y (NPY) Y1 receptor subtype mediates NPY-induced antidepressant-like activity in the mouse forced swimming test.
    Redrobe JP; Dumont Y; Fournier A; Quirion R
    Neuropsychopharmacology; 2002 May; 26(5):615-24. PubMed ID: 11927186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Existence of both neuropeptide Y, Y1 and Y2 receptors in pig spleen: evidence using subtype-selective antagonists in vivo.
    Malmström RE
    Life Sci; 2001 Sep; 69(17):1999-2005. PubMed ID: 11589515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide Y in the central nucleus of amygdala regulates the anxiolytic effect of agmatine in rats.
    Taksande BG; Kotagale NR; Gawande DY; Bharne AP; Chopde CT; Kokare DM
    Eur Neuropsychopharmacol; 2014 Jun; 24(6):955-63. PubMed ID: 24461723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.